Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-30 @ 3:04 AM
Study NCT ID:
NCT07404592
Status:
COMPLETED
Last Update Posted:
2026-02-11
First Post:
2026-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tracheostomy Practices in Adult Intensive Care Units: A Multicentre Study in Izmir
Sponsor:
Izmir City Hospital
Organization:
Study Overview
Official Title:
TRACHEOSTOMY PRACTICES IN ADULT INTENSIVE CARE UNITS IN IZMIR, TURKEY: A MULTICENTRE POINT-PREVALENCE STUDY
Status:
COMPLETED
Status Verified Date:
2026-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IZ-TRACH
Brief Summary:
The primary objective of this study was to determine the point prevalence of tracheostomy in adult intensive care units (ICUs) in Izmir and to evaluate indications, techniques, complications, timing, and short-term outcomes. This multicentre, descriptive point-prevalence study was conducted across seven adult ICUs on September 8, 2025. The study aimed to provide observational data on how tracheostomy is managed in a real-world clinical setting, focusing on the decision-making process and clinical characteristics associated with patient mortality
Detailed Description:
This investigation was designed as a multicentre, descriptive point-prevalence study. On the specified prevalence day, all patients aged 18 years and older who had previously undergone tracheostomy using either surgical or percutaneous techniques in participating centers were included.
The data collection process involved:
* Documentation of ICU structural characteristics, including bed capacity and annual tracheostomy volumes.
* Systematic recording of patient demographics, comorbidities, tracheostomy indications, and the specific techniques used (e.g., Griggs guidewire dilating forceps, Ciaglia single-dilator, or surgical tracheostomy).
* Assessment of early and post-procedural complications.
* Evaluation of the time interval from endotracheal intubation to the tracheostomy procedure and identifying reasons for any delays.
* A 30-day follow-up to assess mortality outcomes for all included patients.
The data collection process involved:
* Documentation of ICU structural characteristics, including bed capacity and annual tracheostomy volumes.
* Systematic recording of patient demographics, comorbidities, tracheostomy indications, and the specific techniques used (e.g., Griggs guidewire dilating forceps, Ciaglia single-dilator, or surgical tracheostomy).
* Assessment of early and post-procedural complications.
* Evaluation of the time interval from endotracheal intubation to the tracheostomy procedure and identifying reasons for any delays.
* A 30-day follow-up to assess mortality outcomes for all included patients.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: